Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 57, Issue 3, Pages 1262-1271
Publisher
Wiley
Online
2012-12-06
DOI
10.1002/hep.26179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
- (2012) Carmela Loguercio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection
- (2012) Alessio Aghemo et al. Hepatitis Monthly
- Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy
- (2012) Michael W. Fried JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 178 INTRAVENOUS SILIBININ-THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C IN THE TRANSPLANT SETTING
- (2012) S. Beinhardt et al. JOURNAL OF HEPATOLOGY
- Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period
- (2012) Zoe Mariño et al. JOURNAL OF HEPATOLOGY
- Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation
- (2012) Janela McClure et al. PLoS One
- Intravenous silibinin as ‘rescue treatment’ for on-treatment non-responders to pegylated interferon/ribavirin combination therapy
- (2011) Karoline Rutter et al. ANTIVIRAL THERAPY
- Differences in the Disposition of Silymarin between Patients with Nonalcoholic Fatty Liver Disease and Chronic Hepatitis C
- (2011) S. J. Schrieber et al. DRUG METABOLISM AND DISPOSITION
- High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy
- (2011) M. Biermer et al. JOURNAL OF VIRAL HEPATITIS
- Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
- (2011) Jessica Wagoner et al. PLoS One
- Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial
- (2010) N. D. Freedman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
- (2010) Gagan Deep et al. CANCER AND METASTASIS REVIEWS
- Multiple effects of silymarin on the hepatitis C virus lifecycle
- (2010) Jessica Wagoner et al. HEPATOLOGY
- Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV–HCV coinfected patient
- (2010) B.A. Payer et al. JOURNAL OF CLINICAL VIROLOGY
- Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy
- (2010) U.P. Neumann et al. JOURNAL OF HEPATOLOGY
- Identification of hepatoprotective flavonolignans from silymarin
- (2010) S. J. Polyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver
- (2010) Nirav Patel et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Silibinin prevents amyloid β peptide-induced memory impairment and oxidative stress in mice
- (2009) P Lu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase
- (2009) Abdelhakim Ahmed–Belkacem et al. GASTROENTEROLOGY
- Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection
- (2009) Chihiro Morishima et al. GASTROENTEROLOGY
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
- (2009) Samer S. El-Kamary et al. PHYTOMEDICINE
- Multitargeted therapy of cancer by silymarin
- (2008) Kumaraguruparan Ramasamy et al. CANCER LETTERS
- The Pharmacokinetics of Silymarin Is Altered in Patients with Hepatitis C Virus and Nonalcoholic Fatty Liver Disease and Correlates with Plasma Caspase-3/7 Activity
- (2008) S. J. Schrieber et al. DRUG METABOLISM AND DISPOSITION
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search